Skip to main content

Arthritis: Drugs

Volume 487: debated on Tuesday 27 January 2009

To ask the Secretary of State for Health how many (a) anti-TNF medicines and (b) disease-modifying anti-rheumatic drugs have been (i) prescribed in hospital and (ii) dispensed in the community in each year since 2000-01. (249261)

Information on the number of prescriptions for anti-TNF medicines and disease-modifying anti-rheumatic medicines in hospitals is not available.

Disease-modifying anti-rheumatic medicines, including anti-TNF medicines, are listed in the British National Formulary (BNF) “chapter 10.1.3—Drugs that suppress the rheumatic disease process”. The following table shows the total number of prescription items dispensed in the community in England for this category and for anti-TNF medicines.

Prescription items of disease-modifying anti-rheumatic medicines dispensed in the community in England1

Thousand

BNF chapter 10.1.3 including anti-TNF drugs

Anti-TNF drugs2

BNF chapter 10.1.3 excluding anti-TNF drugs

2000-01

2,222.6

0.1

2,222.5

2001-02

2,359.1

0.3

2,358.8

2002-03

2,489.4

0.5

2,488.9

2003-04

2,624.5

1.3

2,623.2

2004-05

2,759.0

2.7

2,756.3

2005-06

2,948.6

5.0

2,943.6

2006-07

3,119.4

5.1

3,114.3

2007-08

3,358.5

8.0

3,350.5

2008-09 (April-September)

1,783.5

5.3

1,778.2

1 Medicines can be used to treat more than one condition and it is not possible to identify the different conditions that a medicine was prescribed for. Therefore, some of the items included in this table may not have been used to treat rheumatic disease.

2 Adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade)

Source:

Prescription Cost Analysis system